Dr Craig Lee Weatherhead, DC in Chester, NE - Chiropractor

Dr Craig Lee Weatherhead, DC is a Chiropractor based in Chester, Nebraska. Dr Craig Lee Weatherhead is licensed to practice in Nebraska (license number 1946) and his current practice location is 520 Thayer Ave, Chester, Nebraska. He can be reached at his office (for appointments etc.) via phone at (785) 534-9324.

NPI number for Dr Craig Lee Weatherhead is 1962990051 and his current mailing address is 1682 250 Rd, Beloit, Kansas. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1962990051.

Contact Information

	Dr Craig Lee Weatherhead, DC
	520 Thayer Ave, Chester, NE 68327
	(785) 534-9324
	Not Available

Healthcare Provider's Profile

Full Name	Dr Craig Lee Weatherhead
Gender	Male
Speciality	Chiropractor
Location	520 Thayer Ave, Chester, Nebraska
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1962990051
Provider Enumeration Date: 04/25/2018
Last Update Date: 04/25/2018

Medical Identifiers

Medical identifiers for Dr Craig Lee Weatherhead such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1962990051	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
111N00000X	Chiropractor	1946 (Nebraska)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Craig Lee Weatherhead is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Craig Lee Weatherhead, DC 1682 250 Rd, Beloit, KS 67420-3197 Ph: (785) 534-9324	Dr Craig Lee Weatherhead, DC 520 Thayer Ave, Chester, NE 68327 Ph: (785) 534-9324

News Archive

NEJM hails vismodegib as ‘the greatest advance in therapy yet seen' for advanced BCC

Vismodegib, a new skin cancer drug for patients with advanced basal cell carcinoma tested by TGen, Virginia G. Piper Cancer Center at Scottsdale Healthcare and Mayo Clinic, is hailed as "the greatest advance in therapy yet seen" for advanced basal cell carcinoma in an editorial in the New England Journal of Medicine.

IMS Health to launch comprehensive analytical tool for oncology market

IMS Health, the world's leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced the upcoming launch of IMS Oncology QuantifierTM, a comprehensive, clinically rich analytical tool that enables the company's clients to assess treatment opportunities and guide commercial decisions in the $48 billion global oncology market.

Garmatex, Diagnomics partner to develop healthcare products to prevent hospital-acquired infections

Garmatex Technologies, Inc., a leading inventor of performance fabric and apparel solution-focused technologies, has signed a Letter of Intent ("LOI") for a five year term with Diagnomics Inc., a biotech company that provides next-generation healthcare solutions from personal genomics.

Dabigatran etexilate superior to warfarin for stroke prevention in AF patients

New data from two RE-LY trial sub-group analyses show that dabigatran etexilate provides consistent benefits in stroke in atrial fibrillation (AF) compared to well-controlled warfarin, irrespective of whether patients use antiplatelet or other concomitant therapies, such as the anti-arrhythmics amiodarone or verapamil.

AP examines implementation of China's plan to rebuild health system

The Associated Press tracks the progress in rebuilding the health system in China, eight months after the government launched a three-year $124-billion health care program.

Dr Craig Lee Weatherhead, DC - Chiropractor in Chester, NE